These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 33225754)

  • 1. Advocacy for better metabolic monitoring after antipsychotic initiation: based on data from a French health insurance database.
    Bulteau S; Le Pierres M; Artarit P; Forestier B; Michaud E; Chaslerie A; Bonnot O; Victorri-Vigneau C
    Expert Opin Drug Saf; 2021 Feb; 20(2):225-233. PubMed ID: 33225754
    [No Abstract]   [Full Text] [Related]  

  • 2. Measurement of Metabolic Monitoring in Youth and Adult Medicaid Recipients Prescribed Antipsychotics.
    Edelsohn GA; Parthasarathy M; Terhorst L; Karpov IO; Schuster J
    J Manag Care Spec Pharm; 2015 Sep; 21(9):769-77, 777a-777cc. PubMed ID: 26308224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Metabolic testing rates after initiation of antipsychotic treatment in persons initially treated by conventional mood-stabilizers].
    Verdoux H; Gaudron Y; Auleley GR; Deligne J; Blum-Boisgard C; Thiébaut A; Tournier M
    Encephale; 2013 May; 39 Suppl 1():S22-8. PubMed ID: 23246328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What about regular hematological monitoring during clozapine treatment? A compliance analysis using the French health insurance database.
    Laforgue EJ; Istvan M; Guerlais M; Chaslerie A; Artarit P; Vallot G; Jolliet P; Grall-Bronnec M; Victorri-Vigneau C
    Expert Opin Drug Saf; 2021 Oct; 20(10):1247-1256. PubMed ID: 34085879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a computer-based intervention to enhance metabolic monitoring in psychiatry inpatients treated with second-generation antipsychotics.
    DelMonte MT; Bostwick JR; Bess JD; Dalack GW
    J Clin Pharm Ther; 2012 Dec; 37(6):668-73. PubMed ID: 22845616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
    Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
    Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of the drug exposure definition on the assessment of the antipsychotic metabolic impact in patients initially treated with mood-stabilizers.
    Tournier M; Bégaud B; Cougnard A; Auleley GR; Deligne J; Blum-Boisgard C; Thiébaut AC; Verdoux H
    Br J Clin Pharmacol; 2012 Jul; 74(1):189-96. PubMed ID: 22257309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic Testing for Adults in a State Medicaid Program Receiving Antipsychotics: Remaining Barriers to Achieving Population Health Prevention Goals.
    Morrato EH; Campagna EJ; Brewer SE; Dickinson LM; Thomas DS; Miller BF; Dearing J; Druss BG; Lindrooth RC
    JAMA Psychiatry; 2016 Jul; 73(7):721-30. PubMed ID: 27167755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of long-term (at least 24 weeks) weight gain and metabolic changes between adolescents and adults treated with olanzapine.
    Kryzhanovskaya LA; Xu W; Millen BA; Acharya N; Jen KY; Osuntokun O
    J Child Adolesc Psychopharmacol; 2012 Apr; 22(2):157-65. PubMed ID: 22372514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of monitoring for metabolic effects associated with second generation antipsychotics in patients with schizophrenia on public insurance.
    Moeller KE; Rigler SK; Mayorga A; Nazir N; Shireman TI
    Schizophr Res; 2011 Mar; 126(1-3):117-23. PubMed ID: 21168994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cohort of one million patients initiating antidepressant treatment in France: 12-month follow-up.
    Fagot JP; Cuerq A; Samson S; Fagot-Campagna A
    Int J Clin Pract; 2016 Sep; 70(9):744-51. PubMed ID: 27484351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of monitoring for glucose and lipid dysregulation in adult Medi-Cal patients newly started on antipsychotics.
    Barnett M; VonMuenster S; Wehring H; Popish S; McDonald K; Walker VM; Perry P
    Ann Clin Psychiatry; 2010 Feb; 22(1):9-18. PubMed ID: 20196978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Metabolic side effects of risperidone in early onset schizophrenia].
    Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
    Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-dependent metabolic effects of second-generation antipsychotics in second-generation antipsychotic-naïve French Canadian patients.
    Roy G; Bedard A; Desmarais PA; Jourdain F; Allen S; Michaud D; Ben Amor L
    J Child Adolesc Psychopharmacol; 2010 Dec; 20(6):479-87. PubMed ID: 21186966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Child and adolescent psychiatrists' reported monitoring behaviors for second-generation antipsychotics.
    Rodday AM; Parsons SK; Mankiw C; Correll CU; Robb AS; Zima BT; Saunders TS; Leslie LK
    J Child Adolesc Psychopharmacol; 2015 May; 25(4):351-61. PubMed ID: 25918843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of Adverse Drug Reaction-Related Parameters in Children, Youth, and Young Adults Prescribed Antipsychotic Drugs by General Practitioners.
    Minjon L; van den Ban E; Bazelier MT; Lalmohamed A; Egberts TCG; Heerdink ER
    J Child Adolesc Psychopharmacol; 2022 Feb; 32(1):36-44. PubMed ID: 34619039
    [No Abstract]   [Full Text] [Related]  

  • 18. [Psychiatrists' decision making and monitoring of antipsychotic prescription for elderly schizophrenia patients].
    Jalenques I; Ortega V; Legrand G; Auclair C
    Encephale; 2016 Apr; 42(2):124-9. PubMed ID: 26796558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring of Recommended Metabolic Laboratory Parameters Among Medicaid Recipients on Second-Generation Antipsychotics in Federally Qualified Health Centers.
    Uzal NE; Chavez B; Kosirog ER; Billups SJ; Saseen JJ
    Ann Pharmacother; 2018 Feb; 52(2):160-165. PubMed ID: 28884591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA/APA recommendations for second-generation antipsychotic drugs.
    Morrato EH; Druss B; Hartung DM; Valuck RJ; Allen R; Campagna E; Newcomer JW
    Arch Gen Psychiatry; 2010 Jan; 67(1):17-24. PubMed ID: 20048219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.